NORDIC9: A randomized phase II trial exploring treatment of older patients with metastatic colorectal cancer (mCRC) by comparing full dose monotherapy (S-1 followed by irinotecan) with reduced combination regimen (S-1/oxaliplatin followed by S-1/irinotecan)

Authors :: Bengt Glimelius
Camilla Qvortrup
P. Österlund
Halfdan Sorbye
Åke Berglund
Stine Braendegaard Winther
Per Pfeiffer
Source :: Annals of Oncology. 27:vi203
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.
Abstract: NORDIC9 : A randomized phase II trial exploring treatment of older patients with metastatic colorectal cancer (mCRC) by comparing full dose monotherapy (S-1 followed by irinotecan) with reduced combination regimen (S-1/oxaliplatin followed by S-1/irinotecan)

Subjects :: Oncology
medicine.medical_specialty
business.industry
Colorectal cancer
Hematology
medicine.disease
digestive system diseases
Oxaliplatin
Irinotecan
stomatognathic diseases
Regimen
Older patients
health services administration
Internal medicine
medicine
business
therapeutics
neoplasms
medicine.drug

Tools